Condition
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Treatment of relapsed/refractory AML using anti-FLT3 CAR-T cells
This study is testing a new type of CAR-T cell treatment for people with relapsed or refractory acute myeloid leukemia to see if it is safe and effective.
-
Testing BL-M11D1 for patients with relapsed or refractory acute myeloid leukemia
This study is testing a new treatment called BL-M11D1 to see if it is safe and tolerable for patients with relapsed or refractory acute myeloid leukemia.
Related topics
Quick answers
How many Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.